These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17623792)

  • 1. FDA user fee law poised for passage in Congress but not without stirring up controversy.
    Finkelstein J
    J Natl Cancer Inst; 2007 Jul; 99(14):1072-3. PubMed ID: 17623792
    [No Abstract]   [Full Text] [Related]  

  • 2. Good law from tragic facts--Congress, the FDA, and preemption.
    Annas GJ
    N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383
    [No Abstract]   [Full Text] [Related]  

  • 3. User fees to hasten FDA review.
    Gershon D
    Nature; 1992 Oct; 359(6396):567. PubMed ID: 1406982
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA user fees approved.
    Clin Pharm; 1993 Jan; 12(1):3. PubMed ID: 8428431
    [No Abstract]   [Full Text] [Related]  

  • 5. New law broadens FDA safety authority, renews user fees.
    Fox JL
    Nat Biotechnol; 2007 Nov; 25(11):1189-90. PubMed ID: 17989653
    [No Abstract]   [Full Text] [Related]  

  • 6. Congress may force drug firms to reveal clinical trial data.
    Check E
    Nature; 2004 Sep; 431(7006):232. PubMed ID: 15371992
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeal law that puts "FDA on the payroll of the industry," says former NEJM editor.
    Kmietowicz Z
    BMJ; 2007 Mar; 334(7591):447. PubMed ID: 17332569
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA user fees and innovation.
    Somberg J
    Am J Ther; 2008; 15(2):97. PubMed ID: 18356626
    [No Abstract]   [Full Text] [Related]  

  • 9. New drug law to speed scientific review.
    Nature; 1992 Oct; 359(6396):563. PubMed ID: 1406977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug risks and free speech--can Congress ban consumer drug ads?
    Shuchman M
    N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002
    [No Abstract]   [Full Text] [Related]  

  • 11. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

  • 12. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
    Bierut MB
    Healthspan; 1992 Dec; 9(11):12-4. PubMed ID: 10123552
    [No Abstract]   [Full Text] [Related]  

  • 13. User-fee bill passes US Senate, but legislative hurdles remain.
    Fox JL
    Nat Biotechnol; 2007 Jun; 25(6):611. PubMed ID: 17557086
    [No Abstract]   [Full Text] [Related]  

  • 14. User-fee boost would up safety, reputations. A new paper suggests that drug makers, FDA can't afford not to raise user fees.
    Med Health; 2005 Oct; 59(39):2, 4. PubMed ID: 16279192
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 16. The FDA and congress: differing agendas?
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):116-7. PubMed ID: 20504131
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA user fee plan gets some support from drug makers.
    Weissenstein E
    Mod Healthc; 1992 Aug; 22(33):20. PubMed ID: 10119804
    [No Abstract]   [Full Text] [Related]  

  • 18. New law aims to distance the FDA from the drug industry.
    Lenzer J
    BMJ; 2005 May; 330(7500):1106. PubMed ID: 15891225
    [No Abstract]   [Full Text] [Related]  

  • 19. US presidential candidates diverge on how to help biopharma.
    Matthews S
    Nat Med; 2012 Oct; 18(10):1445. PubMed ID: 23042331
    [No Abstract]   [Full Text] [Related]  

  • 20. Vioxx may go back on sale after scraping past FDA panel.
    Wadman M
    Nature; 2005 Feb; 433(7028):790. PubMed ID: 15729304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.